Results 231 to 240 of about 423,899 (348)
Hyperuricemia as a prognostic factor in pulmonary arterial hypertension
Danielle Bendayan+5 more
openalex +1 more source
Treatment with epoprostenol of pulmonary arterial hypertension following mitral valve replacement for mitral stenosis [PDF]
C. Gregory Elliott
openalex +1 more source
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro+15 more
wiley +1 more source
Effects of Adrenomedullin Inhalation on Hemodynamics and Exercise Capacity in Patients With Idiopathic Pulmonary Arterial Hypertension [PDF]
Noritoshi Nagaya+9 more
openalex +1 more source
Giant pulmonary artery aneurysm in pulmonary arterial hypertension
Agueda Aurtenetxe Pérez+2 more
openaire +3 more sources
Atrial septostomy in the treatment of severe pulmonary arterial hypertension
Frank Reichenberger
openalex +1 more source
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia+2 more
wiley +1 more source
Pathophysiological Insights from a Case of Reversible Pulmonary Arterial Hypertension
D Mukerjee+3 more
openalex +1 more source
Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo+7 more
wiley +1 more source